Ategrity specialty insurance co director buys $499,800 in stock

Published 16/06/2025, 23:12
Ategrity specialty insurance co director buys $499,800 in stock

John Langton Sennott Jr., a director at Ategrity Specialty Insurance Co Holdings (NASDAQ:ASIC), has acquired 29,400 shares of the company’s common stock. The transaction, dated June 12, 2025, was executed at a price of $17 per share, amounting to a total purchase value of $499,800. The shares now trade at $23.50, representing a 38% premium to the director’s purchase price. According to InvestingPro, the company maintains strong financial health with a GOOD overall score and shows solid liquidity metrics.

In addition to this purchase, Sennott also acquired 2,941 restricted stock units on June 11, 2025. These units were granted at no cost and will vest in equal installments over the next three years. Following these transactions, Sennott holds a total of 29,400 shares of common stock directly in the $1.11 billion market cap company. InvestingPro analysis reveals 4 additional investment tips and extensive financial metrics that could help investors make informed decisions about ASIC.

In other recent news, Ategrity Specialty Insurance Company Holdings made a notable entrance on the New York Stock Exchange. The company began trading at $23.65 per share following its initial public offering, which was priced at $17.00 per share. This IPO involved the issuance of 6,666,667 shares of common stock, expected to generate $113.3 million in gross proceeds before accounting for underwriting discounts, commissions, and estimated offering expenses. Additionally, Ategrity has given underwriters a 30-day option to purchase up to an extra 1,000,000 shares at the IPO price, minus underwriting discounts and commissions. J.P. Morgan and Barclays (LON:BARC) are leading the offering as joint lead bookrunning managers and are acting as representatives of the underwriters. These developments mark significant steps for Ategrity Specialty Insurance Company Holdings as it enters the public market.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.